Citations

Clear

2358 citation(s) found for "Yu, Long".

A translational platform for brain-computer interfaces and adaptive neuromodulation: Technical characterization, long-term validation, and implementation of the CorTec brain interchange-BCI2000 ecosystem
Lampert, Frederik , Baker, Matthew R , Engelhardt, William , Gkogkidis, C Alexis , Ayyoubi, Amir Hossein , Fazli Besheli, Behrang , Boom, Max van den , Kellar, Douglas J , Kim, Inyong , Staff, Nathan P , Schalk, Gerwin , Ince, Nuri Firat

Mayo Clinic

Journal of Neural Engineering | November 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1088/1741-2552/aec198 | PMID 43019594 Get It

Abstract Objective: Adaptive neuromodulation systems and implantable brain-computer interfaces (BCIs) are promising therapies for neurological and psychiatric disorders. However, their broader translation into research and clinical practice remains limited by technological complexity, restricted access to implantable research platforms, and the lack of standardized, reproducible experimental workflows. We therefore aimed to develop and validate an open, general-purpose translational ecosystem that enables rapid development, evaluation, and dissemination of novel neuromodulation and implantable BCI paradigms.
Approach: The CorTec Brain Interchange (BIC) implantable neural sensing and stimulation device was integrated with the open-source BCI2000 platform to create a modular, extensible neuromodulation ecosystem. We established a standardized battery of quantitative assessments to characterize implantable neuromodulation systems to comprehensively evaluate the CorTec BIC device through benchtop characterization, long-term preclinical in vivo validation, and a human feasibility demonstration using the benchtop BIC system connected to externalized leads.
Results: Comprehensive benchtop characterization of the BIC device independently validated previously reported performance while extending its evaluation through quantification of recording noise, acquisition and stimulation latencies, and validation of impedance measurements. Long-term in vivo validation in five canines, with the longest implantation exceeding three years, demonstrated stable chronic recordings while also capturing progressive deterioration of individual channels through longitudinal changes in signal quality and impedance. The ecosystem enabled active functional decoding more than two years after implantation, closed-loop stimulation using arbitrary spectral biomarkers, capturing brain stimulation evoked potentials, detection of epilepsy-associated biomarkers and observational assessment of their response to stimulation. In addition, we translated an established one-dimensional BCI cursor-control paradigm to the BIC benchtop system, demonstrating ecosystem portability and feasibility with a human participant. Finally, we share surgical protocols, imaging and analysis pipelines, datasets, and software to facilitate reproducible neuromodulation research.
Significance: We present a versatile, open-source translational ecosystem that supports a wide range of neuromodulation and implantable BCI applications with minimal modification. By combining comprehensive hardware characterization with standardized software tools and experimental workflows, this work provides a practical reference for researchers adopting the BIC platform while establishing a broadly applicable framework for systematic characterization of implantable neuromodulation systems. The ecosystem lowers technical barriers to implantable neurotechnology research, promotes reproducibility, and provides a foundation for accelerating the development and clinical translation of next-generation adaptive neuromodulation and implantable BCI therapies for patients with neurological and psychiatric disorders.
Long-term economic benefits of early cancer detection through enhanced multimodal screening: a modeling study of whole-body MRI and liquid biopsy
Sato, Ryoko , McVeigh, Kim H, Bolan, Candice, Brar, Pamila, Sazama, Naomi, Karow, David

Mayo Clinic

Journal of Comparative Effectiveness Research | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.57264/cer-2026-0099 | PMID 43012102 Get It

Aim: Cancer poses a substantial health and economic burden in the US Although early detection is associated with improved outcomes and lower treatment costs, many cancers are still diagnosed at advanced stages. Enhanced multimodal screening combining whole-body magnetic resonance imaging (WB MRI) and blood-based multicancer early detection (MCED) may shift diagnoses earlier, but its long-term economic impact remains uncertain. Materials & methods: We developed an economic model to estimate expected cancer-related costs under two scenarios: status quo with conventional screening and enhanced multimodal screening incorporating WB MRI and MCED. The analysis included common cancers with an annual incidence of ≥10,000 new cases in the US in 2025. Expected cancer management costs were estimated using incidence-based 5-year stage-specific medical costs. Productivity losses were estimated using a simplified human capital approach, applying published stage-specific work-loss durations to sex-specific annual earnings. Under the intervention arm, conservative, moderate and maximum cancer stage-shift assumptions were evaluated. These scenarios reflected increasing degrees of earlier cancer detection, with a greater proportion of cancers assumed to be diagnosed at earlier stages rather than at advanced stages. Total expected cancer-related costs per person were derived by combining direct medical costs and productivity losses, weighted by cancer risk and stage distribution. Results: Under the status quo, expected cancer-related costs were estimated at $74,431 for men and $78,818 for women. With enhanced multimodal screening under the moderate stage-shift assumption, costs, including screening and false positive workup, declined to about $66,000 and $69,500, respectively, representing approximately 12% reduction. Under the conservative stage-shift assumption, total costs were similar to those under the status quo, whereas under the maximum stage-shift assumption, cost reductions ranged from 24.0% to 24.3% for men and from 24.7% to 25.0% for women. Conclusion: Enhanced multimodal screening may reduce the economic burden of cancer by shifting diagnosis toward earlier stages, although the magnitude of benefit depends substantially on the extent to which cancers are detected at earlier stages in practice. These findings highlight the potential long-term economic value of earlier cancer detection while underscoring the need for prospective evidence on the real-world performance of WB-MRI and MCED screening strategies. Because long-term real-world data for population-level WB-MRI and MCED screening remain limited, these findings should be interpreted as estimates of potential economic impact rather than projections of a specific screening program.
Initial Diabetes Therapy After Coronary Artery Bypass Grafting and Long‐Term Outcomes
Tam, Vincy , Schaff, Hartzell V. , Thao, Viengneesee , Houten, Holly K. Van , Frye, Robert L. , Greason, Kevin L. , AlJamal, Yazan , Spencer, Philip J. , Rowse, Phillip G. , Crestanello, Juan A.

Mayo Clinic

Journal of the American Heart Association | November 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/jaha.126.053850 | PMID 42998247 Get It

ABSTRACT: Background Type 2 diabetes (T2D) is common among patients undergoing coronary artery bypass grafting (CABG), but optimal post‐CABG glucose‐lowering therapy remains uncertain. Methods We conducted a retrospective cohort study using the OptumLabs Data Warehouse of adults with T2D undergoing isolated CABG from 2012–2024. Follow‐up began 30 days after discharge. Glucose‐lowering therapy was modeled as a time‐varying exposure with patients contributing no‐observed‐therapy person‐time until the first qualifying post‐discharge fill. Pairwise comparisons used stabilized inverse probability of treatment weighting. The primary outcome was all‐cause mortality; secondary outcomes were heart failure hospitalization, stroke, and repeat coronary revascularization. Results Among 19,237 patients, 24.9% had no observed post‐discharge therapy, 42.8% received metformin, 22.9% received insulin, and 9.4% received GLP‐1RA/SGLT2i therapy. All active therapies were associated with lower mortality compared with no observed therapy, including GLP‐1RA/SGLT2i (HR 0.71, 95% CI 0.58–0.87), metformin (HR 0.60, 95% CI 0.55–0.66), and insulin (HR 0.75, 95% CI 0.67–0.84). Among active therapies, metformin was associated with lower mortality than insulin (HR, 0.61 [0.54–0.70]); GLP‐1RA/SGLT2i comparisons with metformin and insulin were less precise. Metformin was also associated with lower cumulative incidence of heart failure hospitalization than no observed therapy and insulin, and lower stroke incidence than insulin. Conclusions Observed glucose‐lowering therapy initiation after CABG was associated with lower mortality compared with no observed therapy across all active treatment groups. These findings highlight a potential care gap and suggest that proper initiation of diabetes therapy after CABG represents an important opportunity to improve long‐term outcomes following surgical revascularization.
Delirium and Long-Term Cognitive Trajectories in Cognitively Unimpaired Adults
St Sauver, Jennifer, Schafer, Marissa

Mayo Clinic

JAMA Neurology | November 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1001/jamaneurol.2026.4001 | PMID 42970282 Get It

Importance Delirium is a state of acute confusion characterized by deficits in attention that occurs commonly during hospitalization and is associated with adverse outcomes; however, the association of delirium with longitudinal cognitive trajectories is not fully understood. Objective To evaluate the association of delirium during hospitalization with subsequent development of mild cognitive impairment (MCI), dementia, and longitudinal cognitive trajectories. Design, Setting, and Participants This cohort study used data from participants with hospitalizations in the Mayo Clinic Study of Aging (MCSA) from October 2004 to December 2023. The MCSA is a prospective, population-based longitudinal study of cognitive aging among residents of Olmsted County, Minnesota. Of participants enrolled in the MCSA between 2004 and 2023, individuals who experienced 1 or more hospitalization prior to their last MCSA encounter were included in this study. Participants with dementia at MCSA enrollment or prior to first hospitalization were excluded. Follow-up continued until development of MCI or dementia, last MCSA visit, or the end of the study. Exposure Delirium was identified using a validated natural language processing algorithm applied to clinical notes from hospitalizations, associated emergency department visits, and follow-up within 30 days after hospitalization. Delirium status was modeled as a time-dependent exposure. Main Outcomes and Measures Incident MCI and dementia were assigned through MCSA expert consensus evaluations, including neuropsychological testing performed every 15 months. Association between delirium and development of MCI or dementia was assessed using Cox proportional hazards regression, adjusted for patient age, sex, level of education, and apolipoprotein E (APOE) ε4 allele carrier status; cognitive trajectories were assessed with linear mixed-effects models. Results Of 7030 participants enrolled in the MCSA, 3542 individuals experienced 1 or more hospitalization prior to their last MCSA encounter and were included, and 41 participants with dementia at enrollment or prior to first hospitalization were excluded. The cohort included 3501 participants with at least 1 hospitalization. Median (IQR) age was 74.1 (66.6-80.9) years, 1676 participants (47.9%) were female, median (IQR) level of education was 14 (12-16) years, and 910 participants (26.0%) were APOE ε4 carriers. During a median (IQR) follow-up of 7.2 (4.1-10.4) years, 75 participants (2.1%) had delirium documented within 30 days of hospitalization. Delirium was associated with increased risk of MCI (adjusted hazard ratio [aHR], 3.67; 95% CI, 2.19-6.15) and dementia (aHR, 5.39; 95% CI, 2.94-9.85) and with accelerated decline in longitudinal cognitive testing. Conclusions and Relevance In this cohort study among adults in the MCSA, including those with unimpaired cognition at baseline, delirium during hospitalization was strongly associated with increased risk of MCI and dementia and accelerated cognitive decline in subsequent years.
A Novel Arthroscopic Curette Microphone for Cartilage Defect Preparation in Joint Preservation Surgery: Proof-of-Concept and Tissue-Specific Debridement Audio Features
Schluttenhofer, Adam , Long, Kyndra , V Nagelli, Christopher, Krych, Aaron J , B F Saris, Daniel

Mayo Clinic

CARTILAGE | October 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/19476035261502886 | PMID 42954266 Get It

Objective During open chondral defect preparation, audible debridement sound changes mark the transition from deep cartilage to the calcified cartilage layer. We developed a novel curette microphone to characterize these audio feature differences during arthroscopic defect preparation. Design A piezoelectric curette microphone was used to transmit and record debridement sound from 12 defect preparations (6 deep cartilage, 6 CCL) using human osteochondral allograft remnants. Live audio from the device was used to stop each debridement at the intended level, which was verified histologically. Spectrograms and power-spectral density plots were used to describe the audible transition from deep cartilage to CCL. We compared 22 audio features describing loudness, frequency, and complexity between the two tissue levels. Results Curette strokes against the deep cartilage were louder, higher frequency, and more acoustically complex than strokes against the CCL (p < 0.001). Cartilage debridement generated acoustically complex frequency bands above 2.5 kHz that diminished upon reaching the CCL. Debridement of the CCL produced a simpler audio profile that was predominant below 350 Hz. Conclusion The novel curette microphone presented here transmits high-fidelity debridement audio that can be used to accurately distinguish tissue depth based on the distinct audio profiles of the deep cartilage and CCL.
Long-Term Visual Function and Ocular Health Outcomes after Globe-Sparing Maxillectomy for Orbit-Involving Sinonasal Neoplasms
Sinha, Krishna

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | October 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2971-8305 Get It

Abstract Globe-sparing surgery for orbit-involving sinonasal neoplasms (OISNs) is increasingly an option since the introduction of effective neoadjuvant treatments. Even if vision is preserved, loss of orbital support structures can cause major ocular sequelae. This study analyzed long-term ophthalmic outcomes following globe-sparing maxillectomy (GSM). We retrospectively reviewed all cases of GSM for OISNs with at least 1 year of ophthalmology follow-up at a tertiary care multisite institution from 2005 to 2024. Patient demographics, surgical details, ophthalmic findings, and final oncologic status were recorded. Orbital involvement was graded based on preoperative computed tomography imaging, and outcomes were compared across orbital involvement grades. Thirty-three patients (39% female) were included, with a mean age of 56 ± 18 years and a median follow-up of 2 years (range 1–12 years). Eleven patients (33%) had Grade I, 19 (58%) had Grade II, and 3 (9%) had Grade III involvement. With higher grades of orbital involvement, patients had a higher likelihood of receiving a preoperative ophthalmic exam (p < 0.001) and experiencing preoperative globe malposition (p = 0.015). Patients with higher-grade orbital involvement had a greater frequency of most ophthalmic symptoms postoperatively. Final best visual acuity was 20/40 or better in 82% of Grade I patients and 71% of Grade II/III patients (p = 0.681). GSM for OISNs offers a favorable visual prognosis. Ocular structural and functional impairment were observed at high frequency after surgery, even with lower-grade orbital involvement. Establishing ophthalmic care for all OISN patients is critical to adequately manage ocular sequelae.
Repeat Breast Cancer Surgeries After Segmental Mastectomy Meaningfully Increase Long Term Healthcare Costs
Mathews, Alexandra L., Piltin, Mara A. , Wing, Sam E. , Hamm, Naomi C. , Liu, Yuki , Zheng, Feibi , Kopkash, Kate

Mayo Clinic

Journal of Surgical Oncology | October 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/jso.70419 | PMID 42861517 Get It

ABSTRACT Background and Objectives Among patient with early‐stage breast cancer, breast conservation surgery (BCS) is the most performed surgery, utilized in approximately two‐thirds of patients. While 5‐year overall‐survival rates are strong—typically above 90%—additional re‐excisions can occur in up to 25% of patients who undergo index BCS and some patients will require subsequent surgery for new breast cancer or recurrences. As such, these additional procedures can complicate patients’ pathway to survivorship, negatively impact quality of life, and lead to excess healthcare costs. Methods This retrospective cohort study used linked claims and an electronic healthcare record database to (1) characterize patients at higher risk for additional breast oncologic surgery (aBOS) following BCS, and (2) quantify the long‐term financial impact of aBOS after BCS. In total, 87,190 patients with breast cancer, who had an index BCS between January 1, 2012, to March 31, 2023, were followed for up to 5‐years post‐operatively. Patients with and without aBOS were analyzed, comparing demographics, tumor characteristics, healthcare utilization, and per‐person‐per‐month (PPPM) costs. Results Twenty‐three percent ( n = 20,212) of patients underwent aBOS. These patients were younger, had higher tumor grades and larger tumor sizes, and incurred greater healthcare costs compared to patients who did not undergo a secondary surgery. Conclusion This study highlights significant factors influencing BCS outcomes and healthcare utilization, underscoring the need for tailored therapeutic strategies for patients with breast cancer.
Multichannel Dysfunction Associated With a Dominant-Negative KCNH2 Missense Variant, p.G604S, Results in Action Potential Duration Prolongation and Early Afterdepolarizations in a Patient-Specific, Reengineered Cardiomyocyte Model of Type 2 Long-QT Syndrome
Huynh, Trung , Ye, Dan , Zhou, Wei , Tester, David J. , Garmany, Ramin , Giudicessi, J R , Ackerman, Michael J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | October 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circep.126.014919 | PMID 42861500 Get It

BACKGROUND: Type 2 long-QT syndrome results from KCNH2 -encoded Kv11.1 loss-of-function, but whether secondary inward-current dysfunction amplifies dysfunction remains unclear. METHODS: We characterized sodium ( SCN5A , I Na ) and L-type calcium channel ( CACNA1C , I Ca ) function in KCNH2-G604S and variant-corrected isogenic control induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs). Whole-cell patch-clamp measured action potential duration at 90% repolarization (APD90), and potassium (I Kr ), sodium (I Na ), and calcium (I Ca, L ) currents. Fluo-4 imaging quantified calcium transients. A modified Kernik-Clancy iPSC-CM model incorporated experimentally measured persistent I Na,L and I Ca,L fractions and simulated isolated and combined current defects. RESULTS: KCNH2-G604S caused severe I Kr loss-of-function (72.5% reduction). APD90 was prolonged in G604S-iPSC-CMs (765±58 ms) compared with isogenic controls (368±37 ms; P <0.005), with early afterdepolarizations in 50% of G604S cells. Nifedipine, verapamil, and mexiletine successfully shortened APD90 and abolished early afterdepolarizations. Compared with isogenic control, I Na,L (0.60±0.1% versus 0.26±0.06%; P <0.01), persistent I Ca,L (2.88±0.55% versus 1.26±0.35%; P <0.05), and calcium transient decay times ( P <0.0001) were greater in G604S iPSC-CMs. Increased persistent I Ca,L was phenocopied by E-4031 in isogenic controls and reduced by nifedipine in G604S iPSC-CMs. In silico modeling revealed that the I Kr defect alone prolonged APD90 to only 620 ms. The addition of the observed I Na,L defect had a small additive effect (+20 ms); however, incorporating persistent I Ca,L synergistically extended APD90 to 758 ms, replicating the experimental phenotype. Flux dynamics analysis indicated that this persistent Ca 2+ entry suppresses the forward-mode sodium-calcium exchanger, forcing a compensatory reliance on sarcoplasmic-endoplasmic reticulum Ca-ATPase that primes for calcium instability. CONCLUSIONS: The KCNH2-G604S variant drives a severe multihit phenotype via primary I Kr loss-of-function and secondary state-dependent gain-of-function in persistent I Ca,L . These comprehensive validations demonstrate that the remodeled persistent I Ca,L acts as the essential amplifier driving extreme action potential duration prolongation and Ca 2+ mishandling.
Influence of a long air gap and a ratio 15:1 antiscatter grid on pediatric fluoroscopy and angiography image quality
Fetterly, Kenneth A

Mayo Clinic

Physics in Medicine & Biology | October 8, 2026 | Volume: 71 | Issue: 20 | Pages: 205021

10.1088/1361-6560/aeb220 | PMID 42849503 Get It

Abstract Objective. X-ray angiography and fluoroscopy systems are used to diagnose and treat congenital heart disease in pediatric patients. Among the substantial variabilities in this clinical patient population is that patient weight ranges from <1 kg premature infants to large adolescents. The primary aim of this work was to assess whether an air gap or antiscatter grid is more efficient to mitigate the detrimental influence of scatter radiation on pediatric image quality. Approach. The experimental approach was guided by a 2 year review of pediatric patient imaging conditions. Uniform density water-equivalent phantoms with thickness in the range 6–24 cm were used. For each phantom thickness, the x-ray technique was manually set to mimic the technique selected by automatic dose rate control. The influence of four combinations of air gap and ratio 15:1 antiscatter grid on test object SNR was measured. The air gap was varied by changing the x-ray source to detector distance from 107 to 120 cm. The analytical methods estimated pixel-specific snr 2 contributions to object SNR 2 , thus providing for the use of iodine disks and pediatric implantable devices as test objects. Main results. Patient weight ranged from 0.5 to 134 kg. The relationship between patient water equivalent thickness and weight was demonstrated. For all phantom thicknesses, object SNR was highest using a long air gap, non-grid technique. Decreasing the air gap between the phantom and detector and use of the anti-scatter grid both degraded SNR. These major findings were consistent between iodine disks and clinical devices as test objects. Significance. The findings of this phantom study suggest that a long air gap, non-grid imaging technique may improve radiation dose efficiency of fluoroscopy and angiography imaging across a broad range of pediatric patient sizes.
Straight from the horse’s mouth: assessing anesthesiology resident perceptions and barriers to pain medicine fellowship – a national survey
Long, Timothy R. , Hanson, Andrew, Kohan, Lynn

Mayo Clinic

Regional Anesthesia & Pain Medicine | October 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: rapm-2026-108530

10.1136/rapm-2026-108530 | PMID 42843893 Get It